Trial: 201510089

A Screening Protocol to Determine Tumor Antigen Expression and HLA Sub-Type for Eligibility Determination for Clinical Trials Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs in Subjects with Solid or Hematological Malignancies

Phase

N/A (Cancer Control)

Principal Investigator

Govindan, Ramaswamy

Disease Site

Lung

Learn more about this study at: clinicaltrials.gov